The 4 Cardiology High-Yield Concepts Every FNP Student Must Master Before Boards
Cardiology · 3 min read · October 21, 2026
Demystifying Cardiac Auscultation and Murmurs
Cardiology questions are a guaranteed staple on both the AANP and ANCC board exams. When faced with a murmur vignette, do not panic. Systematic evaluation is your greatest asset. You must instantly recognize where the murmur is best heard, its radiation pattern, and how it responds to dynamic maneuvers like the Valsalva maneuver or standing.
For instance, hypertrophic cardiomyopathy (HCM) and mitral valve prolapse (MVP) are board favorites because they behave counterintuitively. While almost all other murmurs get softer with decreased venous return, HCM and MVP murmurs get louder with standing or Valsalva because the left ventricular chamber size decreases, bringing the structures closer together.
Board Clinical Pearl: Think stiff for aortic stenosis (systolic, crescendo-decrescendo radiating to the neck) and floppy for mitral regurgitation (systolic, holosystolic radiating to the axilla). Memorize the radiation patterns—they are classic board exam giveaways!
Heart Failure Guidelines and Pharmacotherapy Updates
Heart failure with reduced ejection fraction (HFrEF) management is heavily tested, and you are expected to know the foundational four-pillar pharmacotherapy. Gone are the days of starting ACE inhibitors alone and waiting. Modern guidelines emphasize early initiation of disease-modifying agents to reduce mortality.
The core pillars include ARNI (or ACEi/ARB), beta-blockers (specifically carvedilol, metoprolol succinate, or bisoprolol), mineralocorticoid receptor antagonists (MRAs like spironolactone), and SGLT2 inhibitors (empagliflozin or dapagliflozin), which are now standard even in patients without diabetes.
Board Clinical Pearl: Always check renal function and potassium levels 1 to 2 weeks after starting or adjusting an ACEi, ARB, or MRA. A serum creatinine rise of up to 30% is acceptable, but anything beyond that warrants immediate investigation for bilateral renal artery stenosis.
Decoding Hypertension Guidelines and Risk Stratification
Hypertension management questions test your ability to apply ACC/AHA staging and determine when to initiate pharmacological treatment based on atherosclerotic cardiovascular disease (ASCVD) risk. Remember that Stage 1 hypertension (130-139 / 80-89 mmHg) only requires medication initiation if the patient has clinical CVD or a 10-year ASCVD risk of 10% or higher. Otherwise, start with aggressive lifestyle modifications.
Furthermore, you must recognize compelling indications for specific drug classes. For example, a patient with hypertension and diabetes with proteinuria needs an ACE inhibitor or ARB for renal protection. A patient with a history of a myocardial infarction requires a beta-blocker.
Board Clinical Pearl: Never combine an ACE inhibitor with an ARB or a direct renin inhibitor due to the drastically increased risk of hyperkalemia, hypotension, and acute kidney injury.
Spotting Peripheral Artery Disease vs. Chronic Venous Insufficiency
Lower extremity vascular complaints show up frequently, and boards love testing your ability to differentiate arterial from venous pathology. Peripheral artery disease (PAD) presents with intermittent claudication—pain with walking that is relieved by rest—along with cool, shiny skin, diminished pulses, and dependent rubor. Chronic venous insufficiency (CVI) presents with aching legs that worsen with prolonged standing, accompanied by edema, brownish hyperpigmentation (stasis dermatitis), and normal pulses.
When evaluating suspected PAD in the outpatient clinic, your first-line diagnostic test is the Ankle-Brachial Index (ABI). An ABI value of 0.90 or less is diagnostic for PAD.
You have got this! Cardiology can seem dense, but breaking it down into systematic physiologic principles makes it entirely manageable. Take a deep breath, trust your clinical intuition, and remember that every expert nurse practitioner started right where you are today. For more targeted practice questions, detailed rationales, and high-yield review materials, visit us at The FNP Review.